373110.KQ
Xcell Therapeutics, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 1,120.00
−2.44%Margins
Gross margin
-48.2%
EBITDA margin
-223.1%
EBIT margin
-319.3%
Net margin
-253.5%
FCF margin
-238.9%
-255.6%
Return on equity
-87.6%
Return on assets
-143.5%
Return on invested capital
0.32x
Asset turnover
-KRW 10.2B
Cash from operations
KRW 304
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026